SCHEDULE: BlackRock Reports Stake in Health Catalyst

BlackRock, Inc. has updated its Schedule 13G filing, disclosing beneficial ownership of 1.5% of Health Catalyst, Inc.'s common stock as of June 30, 2026.

Summary

• BlackRock, Inc. has filed an amendment to its Schedule 13G, reporting its beneficial ownership of Health Catalyst, Inc. common stock.
• As of June 30, 2026, BlackRock beneficially owned 1,128,517 shares, representing 1.5% of the class of securities.
• This ownership is held through various business units of BlackRock, Inc. and its subsidiaries.
• BlackRock has sole voting power and sole dispositive power over these shares.
• The filing confirms that no single person's interest in the common stock exceeds five percent.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as it is a routine disclosure of beneficial ownership by an institutional investor and does not contain operational or financial performance updates for Health Catalyst.

Positives

• BlackRock's continued investment indicates confidence in Health Catalyst's long-term prospects.
• The filing is an update, suggesting ongoing monitoring and management of the investment portfolio.

Negatives

• BlackRock's stake is relatively small (1.5%), suggesting it is not a controlling or significantly influential shareholder.
• The filing does not provide details on the rationale behind the investment or any strategic intentions.

Risks

• The filing does not explicitly mention any risks associated with the investment or the company.
• Potential future changes in BlackRock's investment strategy could lead to divestment, impacting Health Catalyst's stock price.

Future Outlook

The filing itself does not contain forward-looking statements or guidance from Health Catalyst, Inc. It is a disclosure of beneficial ownership by BlackRock, Inc.

Management Comments

• BlackRock, Inc. certifies that the securities were acquired and are held in the ordinary course of business and were not acquired or held for the purpose of or with the effect of changing or influencing the control of the issuer.

Industry Context

StockSavvy.ai notes that large institutional investors like BlackRock frequently update their beneficial ownership filings. This filing indicates BlackRock's ongoing interest in the healthcare technology sector, where Health Catalyst operates.

Comparison to Industry Standards

• As a Schedule 13G filing, this represents a passive investment by BlackRock, which is common for institutional investors holding less than 5% of a company's stock.
• The 1.5% stake is typical for a diversified portfolio managed by a large asset manager like BlackRock, aiming for broad market exposure rather than concentrated influence.

Stakeholder Impact

• Shareholders: The filing confirms a significant institutional investor's stake, which can be viewed positively for stability, but the small percentage limits direct influence.
• Management: The filing is a standard disclosure and does not directly impact management's day-to-day operations, but signals continued institutional oversight.

Next Steps

• BlackRock will continue to monitor its investment in Health Catalyst, Inc.
• Future amendments to the Schedule 13G will be filed if BlackRock's beneficial ownership changes significantly.

Key Dates

Keywords

Health Catalyst, BlackRock, Schedule 13G, Beneficial Ownership, Common Stock, Investment, Securities